Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q1 2026 · 10-Q
Revenue$5.02M$5.02M−1.9% vs Q1 2025 Net Income-$283.13K-$283.13KN/M vs Q1 2025 EPS, diluted—
Gross Profit$3,001,294−11.7% Operating Income-$286,288N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flow-$812,464N/M Free Cash Flowderived-$977,266N/M Margins · derivedGross margin59.8%−6.7 pt vs Q1 2025
Operating margin-5.7%−4.0 pt vs Q1 2025
Net margin-5.6%−5.9 pt vs Q1 2025
ended Dec 31, 2025 · filed Feb 17, 2026 · 48 d after period end